OTUD1-Notch2-ICD轴协调同种异体T细胞介导的移植物抗宿主病
该研究探讨泛素-蛋白酶体系统对异基因造血干细胞移植后急性移植物抗宿主病(aGVHD)的影响,发现去泛素化酶OTUD1是aGVHD的关键调节因子,通过剪切NICD的K1770位点泛素促进Th1和Th17细胞分化,筛选FDA药物库发现达格列净可抑制OTUD1/NICD轴并延长aGVHD小鼠生存。
要点
- OTUD1是aGVHD的关键调节因子
- OTUD1通过剪切NICD K1770位点泛素促进Th1/Th17分化
- 达格列净抑制OTUD1/NICD轴并延长aGVHD小鼠生存
核心结论
- OTUD1在T细胞介导的同种异体反应中发挥此前未知的作用,靶向OTUD1是缓解aGVHD有前景的治疗策略。
研究设计与样本
- 研究采用实验性研究设计,包含小鼠aGVHD模型和FDA批准药物库筛选。
主要发现
- 异基因造血干细胞移植后CD4+ T细胞活化升高OTUD1蛋白水平,OTUD1与Notch2-ICD(NICD)相互作用并剪切NICD的K1770位点泛素,诱导T细胞中NICD蛋白积累。
- OTUD1驱动的NICD信号促进Th1和Th17细胞的分化与功能,放大aGVHD级联反应。
- 通过筛选FDA批准药物库,鉴定出达格列净为靶向OTUD1/NICD轴的抑制剂。
- 给予达格列净显著延长aGVHD小鼠的生存。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Disorders of the ubiquitin-proteasome system (UPS) are known to influence the incidence and mortality of various diseases. It remains largely unknown whether and how the UPS affects the onset and progression of acute graft-verus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This study demonstrated that the deubiquitinase OTUD1 is an essential regulator of aGVHD. Activation of CD4+ T cells after allo-HSCT, elevated the protein levels of OTUD1, which in turn interacted with the Notch2-ICD (NICD) to cleave the ubiquitin of NICD at the K1770 site, thereby inducing NICD protein accumulations in T cells. OTUD1-driven NICD signaling promoted the differentiation and functions of Th1 and Th17 cells and amplified the cascade of aGVHD. Moreover, by screening a FDA-approved drugs library the study identified dapagliflozin as an inhibitor targeting the OTUD1/NICD axis. Dapagliflozin administration significantly prolonged the survival of aGVHD mice. This study characterized a previously unknown role of OTUD1 in T cell-mediated allogeneic responses and provided a promising therapeutic strategy to target OTUD1 for the alleviation of aGVHD.
引用
- Cheng Q, Wang D, Lai X, et al. The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host disease. Blood. 2023. PMID: 36574342. doi:10.1182/blood.2022017201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。